Fundraising Fox
Allergios
Founded 2020 · 1 known investors
Find your way into Allergios
Sign up to see every warm intro you have to Allergios
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Allergios team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Allergios develops an in-vitro allergy diagnostic that visualizes allergic responses by analyzing how a patient's blood serum induces basophil degranulation, using a disposable microfluidic chip, an optical reader (GranulEye), and AI-based analysis software. The system is aimed at clinicians for diagnosing IgE-mediated allergies, starting with food allergies as an alternative to the food challenge test.
Investors · 1
NLClisted by NLCAmsterdam
How we know: NLC's portfolio page · Not right? Tell us
Frequently asked questions
- What does Allergios do?
- Allergios develops an in-vitro allergy diagnostic that visualizes allergic responses by analyzing how a patient's blood serum induces basophil degranulation, using a disposable microfluidic chip, an optical reader (GranulEye), and AI-based analysis software. The system is aimed at clinicians for diagnosing IgE-mediated allergies, starting with food allergies as an alternative to the food challenge test.
- Who are Allergios's investors?
- Allergios's investors include NLC.